» Articles » PMID: 32594095

Meteorin-Like (METRNL) Attenuates Myocardial Ischemia/Reperfusion Injury-Induced Cardiomyocytes Apoptosis by Alleviating Endoplasmic Reticulum Stress Via Activation of AMPK-PAK2 Signaling in H9C2 Cells

Overview
Journal Med Sci Monit
Date 2020 Jun 29
PMID 32594095
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

BACKGROUND Myocardial ischemia mediates the progression of multiple cardiovascular diseases and leads to serious damage to the morphology, function, and metabolism of cardiomyocytes. The serum level of the hormone Meteorin-like (METRNL) was lower in patients with coronary artery disease and was negatively correlated with inflammatory cytokines. The aim of the present study was to determine the relationship between METRNL and myocardial ischemia/reperfusion (MI/R) injury, and investigate the molecular mechanisms implicated the pathogenesis of myocardial ischemia. MATERIAL AND METHODS In the present study, H9C2 cells underwent oxygen-glucose deprivation and reperfusion (OGD/R) treatment to establish a MI/R cell model. Quantitative real-time polymerase chain reaction was performed to analyze the expression of target gene. Western blot was used to evaluate the protein expression. Cell Counting Kit-8 assay was employed to detect the cell viability. Enzyme-linked immunosorbent assay was carried out to determine the levels of inflammatory cytokines. Finally, flow cytometry and TUNEL staining were used to detect the apoptotic levels of cardiomyocytes. RESULTS The results showed that the expression of METRNL was downregulated in H9C2 cells during OGD/R. Interestingly, METRNL overexpression inhibited the inflammation, apoptosis and endoplasmic reticulum stress in H9C2 cells during OGD/R, which were totally reversed by PAK2 silencing. In addition, METRNL overexpression induced activation of AMPK-PAK2 signaling cascade. CONCLUSIONS METRNL attenuates MI/R injury-induced cardiomyocytes apoptosis by alleviating endoplasmic reticulum stress via activation of AMPK-PAK2 signaling in H9C2 cells. Our findings support that METRNL might be a promising target for treatment of myocardial ischemia in the future.

Citing Articles

Metrnl ameliorates myocardial ischemia-reperfusion injury by activating AMPK-mediated M2 macrophage polarization.

Chen D, Feng Y, Wang H, Lu C, Liu D, Gong C Mol Med. 2025; 31(1):98.

PMID: 40082768 PMC: 11907862. DOI: 10.1186/s10020-025-01150-4.


Metrnl and Cardiomyopathies: From Molecular Mechanisms to Therapeutic Insights.

Xu M, Liu X, Lu L, Li Z J Cell Mol Med. 2025; 29(2):e70371.

PMID: 39853716 PMC: 11756984. DOI: 10.1111/jcmm.70371.


Adipokines and their potential impacts on susceptibility to myocardial ischemia/reperfusion injury in diabetes.

Han R, Huang H, Zhu J, Jin X, Wang Y, Xu Y Lipids Health Dis. 2024; 23(1):372.

PMID: 39538244 PMC: 11558907. DOI: 10.1186/s12944-024-02357-w.


Elevated meteorin-like protein from high-intensity interval training improves heart function via AMPK/HDAC4 pathway.

Wang Y, Yuan J, Liu H, Chen J, Zou J, Zeng X Genes Dis. 2024; 11(6):101100.

PMID: 39281832 PMC: 11400619. DOI: 10.1016/j.gendis.2023.101100.


Metrnl: a promising biomarker and therapeutic target for cardiovascular and metabolic diseases.

Dong W, Hu C, Hu M, Gao Y, Hu Y, Li K Cell Commun Signal. 2024; 22(1):389.

PMID: 39103830 PMC: 11301845. DOI: 10.1186/s12964-024-01767-8.


References
1.
Dadmanesh M, Aghajani H, Fadaei R, Ghorban K . Lower serum levels of Meteorin-like/Subfatin in patients with coronary artery disease and type 2 diabetes mellitus are negatively associated with insulin resistance and inflammatory cytokines. PLoS One. 2018; 13(9):e0204180. PMC: 6136801. DOI: 10.1371/journal.pone.0204180. View

2.
Heusch G, Musiolik J, Gedik N, Skyschally A . Mitochondrial STAT3 activation and cardioprotection by ischemic postconditioning in pigs with regional myocardial ischemia/reperfusion. Circ Res. 2011; 109(11):1302-8. DOI: 10.1161/CIRCRESAHA.111.255604. View

3.
Beltran C, Pardo R, Bou-Teen D, Ruiz-Meana M, Villena J, Ferreira-Gonzalez I . Enhancing Glycolysis Protects against Ischemia-Reperfusion Injury by Reducing ROS Production. Metabolites. 2020; 10(4). PMC: 7240969. DOI: 10.3390/metabo10040132. View

4.
Tabas I, Ron D . Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat Cell Biol. 2011; 13(3):184-90. PMC: 3107571. DOI: 10.1038/ncb0311-184. View

5.
Omidkhoda N, Wallace Hayes A, Reiter R, Karimi G . The role of MicroRNAs on endoplasmic reticulum stress in myocardial ischemia and cardiac hypertrophy. Pharmacol Res. 2019; 150:104516. DOI: 10.1016/j.phrs.2019.104516. View